Eyenovia’s piezo-print latanoprost microdose shows positive results

A proof-of-concept study of a microdose of latanoprost 0.005% showed positive results, according to a press release from Eyenovia.
The EYN PG21 study evaluated 60 eyes of 30 healthy volunteers who received one microdose of piezo-print latanoprost each day for 2 consecutive days. Drug administration volume was reduced by 75%, as the dose was accurately and directly administered to the corneal surface, the release said. In addition, diurnal IOP was reduced up to 29% from baseline unmedicated IOP, which is consistent with standard latanoprost drops.
“We believe these compelling results

ACP: CMS ‘Pathway to Success’ is a bumpy one

The American College of Physicians said in a press release there were good things and bad things about the new CMS plan known as Pathways to Success — a plan the federal agency said overhauls rules for Accountable Care Organization in the Medicare Shared Savings Program established by the Affordable Care Act.
The new initiative moves toward paying providers for the value of care, not just volume of services, Seema Verna, CMS Administrator, said in a conference call with reporters last week. She said this long-standing bipartisan concept is borne (Read more...)

ACP: CMS ‘Pathway to Success’ is a bumpy one

The American College of Physicians said in a press release there were good things and bad things about the new CMS plan known as Pathways to Success — a plan the federal agency said overhauls rules for Accountable Care Organization in the Medicare Shared Savings Program established by the Affordable Care Act.
The new initiative moves toward paying providers for the value of care, not just volume of services, Seema Verna, CMS Administrator, said in a conference call with reporters last week. She said this long-standing bipartisan concept is borne (Read more...)